PetMed Express Announces Upcoming Earnings Call Details

Author: Evelyn Baker Updated: 05-27-2025 04:20 PM

PetMed Express, Inc. Earnings Call Announcement

PetMed Express, Inc., known as PetMeds, is gearing up to hold an important conference call that aims to unveil the financial results for the fourth quarter and the entire fiscal year. This anticipated event is set for an upcoming Tuesday, and it shines a spotlight on the company's steadfast growth in the pet healthcare industry.

Conference Call Details

Scheduled for June 10, the call will commence at 4:30 PM Eastern Time, with leadership from PETS management guiding the proceedings. Following a detailed overview of the financial achievements, participants will have the chance to engage in a question-and-answer segment, fostering open communication between the company and interested stakeholders.

For those eager to join, the company encourages dialing in 5-10 minutes ahead of the start time. Here are the pertinent details:

Date: Tuesday, June 10
Time: 4:30 PM Eastern (1:30 PM Pacific)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast access: A direct link is available for those who prefer an online format.

Replay Information

After the live conference call, a recorded version will be available for those who wish to listen later. This convenient feature will go live after 7:30 PM Eastern Time on the same day and will remain accessible until June 24, offering ample opportunity for review.

Details for accessing the replay are as follows:

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13753433

About PetMed Express, Inc.

Founded in 1996, PetMed Express, Inc. has become a leader in the direct-to-consumer pet healthcare market. Operating as a nationwide online pharmacy, PetMeds is dedicated to providing pet owners with quality health solutions. The company is licensed to operate in all 50 states and prides itself on having expert pharmacists ready to assist with all manner of pet care needs.

Their extensive array of products includes both branded and generic pharmaceuticals, compounded medications, and a range of over-the-counter supplements and nutrition. By focusing on value and convenience, PetMeds seeks to empower pet parents and enhance the quality of life for pets, whether they be dogs, cats, or even horses.

For those interested in exploring more about what PetMeds offers, the company directs individuals to visit their comprehensive websites, which are dedicated to providing a valuable resource for pet wellness.

Contact Information for Investors

For investors looking to engage further or for inquiries regarding the earnings call, PetMed Express has provided clear contact points:

ICR, LLC
John Mills
(646) 277-1254
Reed Anderson
(646) 277-1260
Email: investor@petmeds.com

Frequently Asked Questions

What is the purpose of the upcoming earnings call?

The earnings call aims to discuss the financial results for PetMed Express for the fourth quarter and the full fiscal year.

When will the earnings call take place?

The call is scheduled for June 10 at 4:30 PM Eastern Time.

How can I participate in the conference call?

You can dial into the call using the provided U.S. or international phone numbers, or you can access the webcast online.

Will there be a replay of the call available?

Yes, a replay of the call will be available after 7:30 PM Eastern Time on the same day through June 24.

Who can I contact for investor inquiries?

For inquiries, you can contact John Mills or Reed Anderson at ICR, LLC, or email investor@petmeds.com.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.